June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Characterization of human ocular fibroblast-subpopulations to prevent fibrosis following fistulating glaucoma surgeries
Author Affiliations & Notes
  • Thomas Stahnke
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Marian Löbler
    Institute of Biomedical Engineering, University of Rostock, Rostock, Germany
  • Andreas Wree
    Institute of Anatomy, University of Rostock, Rostock, Germany
  • Oliver Stachs
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Klaus-Peter Schmitz
    Institute of Biomedical Engineering, University of Rostock, Rostock, Germany
  • Rudolf Guthoff
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Footnotes
    Commercial Relationships Thomas Stahnke, None; Marian Löbler, None; Andreas Wree, None; Oliver Stachs, None; Klaus-Peter Schmitz, None; Rudolf Guthoff, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2139. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Thomas Stahnke, Marian Löbler, Andreas Wree, Oliver Stachs, Klaus-Peter Schmitz, Rudolf Guthoff; Characterization of human ocular fibroblast-subpopulations to prevent fibrosis following fistulating glaucoma surgeries. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2139.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Fibrotic re-stenosis following fistulating glaucoma surgeries is the major factor for a postoperative decrease in liquid drain. Hence, one of the most important clinical goals is to develop strategies for fibrosis prevention. This study aimed at characterization of fibrotic potential of different primary human ocular fibroblast-subpopulations. Particularly, we focused on the TGF-b pathway. As this signaling pathway is involved in fibrosis, we investigated its implication in extracellular matrix (ECM) component synthesis and secretion in different ocular fibroblast-subpopulations.

Methods: Human primary fibroblasts from choroidea (hCF), sclera (hSF), Tenon capsule (hTF), and orbital fat tissue (hOF) were isolated and cultured. For immunocytochemical analysis cells were cultured on coverslips and fixed. Incubation with primary antibodies directed against TGF-b pathway components and ECM proteins was carried out followed by incubation with Cy2 and Cy3 conjugated secondary antibodies. Coverslips were mounted with DAPI-containing mounting medium. To analyze protein lysates 1-D-SDS-PAGE and Western blotting were performed according to the standard protocols. Proteins were transferred to PVDF-membranes and antibodies were used to detect TGF-b pathway components. Targets were analyzed by enhanced chemiluminescence (ECL) detection method followed antibody incubation.

Results: Cytokine TGF-b1 and the relevant receptors TGF-b-receptor 1 and 2 expression was demonstrated in every fibroblast-subpopulation. Moreover, TGF-b pathway activation could be observed by phosphorylation specific translocation of the downstream mediators (smad 2 and 3) into the nuclei. However, the level of activation and ECM protein synthesis was different between fibroblast-subpopulations with lowest levels in hCF cultures.

Conclusions: Cell culture model of primary ocular fibroblast-subpopulations pave the way for comparative analyzing of fibrotic processes. Moreover, tissue-specific inhibition of cell proliferation, ECM synthesis or transformation into fibrotic active myofibroblasts could be possible. Exploring the influence of TGF-b pathway inhibitors between different fibroblast-subpopulations opens up specific possibilities in cell population dependent prevention of postoperative scarring processes and fibrosis after fistulating glaucoma surgeries.

Keywords: 765 wound healing • 490 cytokines/chemokines  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×